| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |